HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insuk Sohn Selected Research

Biomarkers (Surrogate Marker)

1/2020Dysregulated miRNA in a cancer-prone environment: A study of gastric non-neoplastic mucosa.
1/2020Spontaneous mutations in the single TTN gene represent high tumor mutation burden.
1/2020Prediction of tumor doubling time of lung adenocarcinoma using radiomic margin characteristics.
1/2019Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer.
1/2018Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication.
1/2017Pathologic stratification of operable lung adenocarcinoma using radiomics features extracted from dual energy CT images.
1/2016To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients.
4/2015A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
9/2014Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
4/2011Mutational hotspots in the mitochondrial genome of lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Insuk Sohn Research Topics

Disease

32Neoplasms (Cancer)
01/2022 - 04/2006
10Stomach Neoplasms (Stomach Cancer)
03/2021 - 01/2012
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2014
5Neoplasm Metastasis (Metastasis)
04/2019 - 07/2015
4Adenocarcinoma of Lung
01/2020 - 10/2015
4Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2013
3Lymphatic Metastasis
01/2022 - 09/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 01/2012
2Carcinoma (Carcinomatosis)
01/2021 - 01/2013
2Ovarian Neoplasms (Ovarian Cancer)
04/2020 - 07/2012
2Ovarian Epithelial Carcinoma
04/2020 - 07/2017
2Crohn Disease (Crohn's Disease)
02/2019 - 05/2018
2Triple Negative Breast Neoplasms
12/2018 - 04/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2018 - 12/2015
2Body Weight (Weight, Body)
01/2005 - 09/2004
1Infections
04/2021
1Sarcopenia
03/2021
1Pathologic Complete Response
11/2020
1Lymphoma (Lymphomas)
11/2020
1Lung Diseases (Lung Disease)
09/2020
1Carcinogenesis
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
11/2019
1Emphysema
07/2019
1Neutropenia
01/2019
1Breast Neoplasms (Breast Cancer)
12/2018
1Pediatric Crohn's disease
05/2018
1Pneumothorax
12/2016
1Critical Illness (Critically Ill)
12/2016
1Colonic Neoplasms (Colon Cancer)
03/2016
1Leiomyoma (Uterine Fibroids)
01/2016

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2011
5ParaffinIBA
01/2020 - 01/2014
4Formaldehyde (Formol)FDA Link
01/2020 - 03/2014
3MicroRNAs (MicroRNA)IBA
01/2020 - 07/2015
3gadolinium ethoxybenzyl DTPAFDA Link
04/2019 - 09/2015
3Capecitabine (Xeloda)FDA Link
01/2016 - 01/2012
3Proteins (Proteins, Gene)FDA Link
05/2015 - 09/2004
3Complementary DNA (cDNA)IBA
03/2014 - 01/2005
2LipidsIBA
04/2021 - 01/2005
2Infliximab (Remicade)FDA Link
02/2019 - 05/2018
2Anaplastic Lymphoma KinaseIBA
01/2018 - 10/2015
2Messenger RNA (mRNA)IBA
01/2018 - 01/2013
2PlatinumIBA
07/2017 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
10/2015 - 01/2012
2Biological ProductsIBA
07/2015 - 04/2006
2Simvastatin (Zocor)FDA LinkGeneric
02/2015 - 06/2014
2Cetuximab (Erbitux)FDA Link
02/2015 - 06/2014
2Irinotecan (Camptosar)FDA LinkGeneric
02/2015 - 06/2014
1Eosine Yellowish-(YS) (Eosin)IBA
01/2022
1Hematoxylin (Haematoxylon)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
03/2021
1Keratins (Keratin)IBA
01/2021
1AnthracyclinesIBA
11/2020
1Asparaginase (Elspar)FDA Link
11/2020
1Amikacin (A.M.K)FDA LinkGeneric
09/2020
1Clofazimine (Lamprene)FDA Link
09/2020
1AlbuminsIBA
05/2020
1BilirubinIBA
05/2020
1Antihypertensive Agents (Antihypertensives)IBA
04/2020
1tyramine-deoxysorbitolIBA
04/2020
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2020
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
04/2020
1Angiotensin Receptor AntagonistsIBA
04/2020
1CreatinineIBA
11/2019
1Cystatin CIBA
11/2019
1Phenobarbital (Luminal)FDA Link
02/2019
1guanosine 5'-monophosphorothioateIBA
01/2019
1human ERBB2 proteinIBA
01/2019
12-mercaptopurineIBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1CopperIBA
12/2018
1ManganeseIBA
12/2018
1Trace Elements (Biometals)IBA
12/2018
1SeleniumIBA
12/2018
1MolybdenumIBA
12/2018
1Thymidylate SynthaseIBA
12/2018
1IntegrinsIBA
01/2018
1AntigensIBA
07/2017
1Blood Proteins (Serum Proteins)IBA
03/2016
1EverolimusFDA Link
01/2016
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2015
1human MIRN664 microRNAIBA
07/2015

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2022 - 04/2010
4Chemoradiotherapy
11/2020 - 01/2012
4Therapeutics
12/2013 - 04/2010
3Immunotherapy
03/2021 - 01/2017
3Adjuvant Chemotherapy
10/2015 - 01/2014
2Radiotherapy
10/2015 - 01/2012
2Ligation
03/2014 - 12/2013
1Anesthesia
01/2022
1General Anesthesia
01/2022
1Pneumonectomy (Lung Volume Reduction)
07/2019
1Gastrectomy
11/2018
1Precision Medicine
01/2018
1Liver Transplantation
01/2018
1Enteral Nutrition (Feeding, Tube)
12/2016
1High-Intensity Focused Ultrasound Ablation
01/2016
1Adjuvant Chemoradiotherapy
10/2015
1Hepatectomy
07/2015